Related Experiment Video
Updated: Sep 2, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin
J L Plantier1, R Berthier, Y Rival
1CEA, Laboratoire d'Hématologie, INSERM U217, Département de Biologie Moléculaire et Structurale, Grenoble, France.
Abstract:
An efficient method for the culture of human megakaryocyte precursors in serum-free medium has been developed facilitating study of the effect of regulators of megakaryocyte growth and maturation without interference by serum-derived factors. We have investigated how megakaryocytes and their precursors respond to the procoagulant enzyme, thrombin. In addition to its already documented agonist effect on mature megakaryocytes, thrombin was found to have a marked inhibitory effect on the growth of megakaryocyte colonies from CD34+ bone marrow cells stimulated by IL3. This inhibitory effect, not previously reported, was selective for megakaryocytic cells. The growth of granulomonocytic and erythroid colonies was not affected. A monoclonal antibody which neutralized the effect of exogenous transforming growth factor beta (TGF beta) was unable to fully neutralize the inhibitory effect of thrombin. With the use of a synthetic peptide, corresponding to the tethered thrombin receptor ligand, and of a recombinant inactive form of thrombin, we provide direct evidence that both the inhibitory effect of thrombin on megakaryocyte proliferation and its agonist effect on mature megakaryocytes are mediated by a receptor analogous to the recently cloned platelet thrombin receptor.
Insights
Thrombin inhibits megakaryocyte precursor growth, a novel finding. This effect, mediated by a specific receptor, impacts megakaryocyte development without affecting other blood cell types.
Area of Science:
- Hematology
- Cell Biology
- Biochemistry
Background:
- Serum-free culture methods enable studying megakaryocyte regulators without serum interference.
- Thrombin is a known agonist for mature megakaryocytes.
Purpose of the Study:
- To investigate the effects of thrombin on megakaryocytes and their precursors.
- To elucidate the mechanism behind thrombin's influence on megakaryopoiesis.
Main Methods:
- Developed serum-free culture for human megakaryocyte precursors.
- Utilized CD34+ bone marrow cells stimulated with IL3.
- Employed a monoclonal antibody against TGF-beta and a synthetic thrombin receptor ligand peptide.
Main Results:
- Thrombin significantly inhibited megakaryocyte colony growth from CD34+ cells.
- This inhibitory effect was specific to megakaryocytic cells, sparing granulomonocytic and erythroid lineages.
- Transforming growth factor beta (TGF-beta) neutralization did not fully block thrombin's inhibitory action.
- Evidence suggests thrombin's effects are mediated by a receptor similar to the platelet thrombin receptor.
Conclusions:
- Thrombin exhibits a novel inhibitory role in megakaryocyte precursor proliferation.
- The findings highlight a specific receptor-mediated mechanism for thrombin's dual effects (inhibition and agonism) on megakaryocytes.
Related Concept Videos
Enzyme-linked Receptors
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis

